Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(24):1803; doi:10.1093/jnci/dji459
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

In Brief

The first 10% of the full text of this article appears below.

Screening Approach Finds Early- and Late-Stage Ovarian Cancers—And False Positives

A new study has found that screening for ovarian cancer using transvaginal ultrasound (TVU) or testing for a bioprotein marker called CA-125 can accurately detect ovarian cancer, but the tests also have a high false-positive rate.

The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial screened 28,816 healthy women for . . . [Full Text of this Article]

Study Examines EGFR Mutations in Glioblastoma

Study Examines Esophageal Cancer Risk and NSAID Use in Barrett Esophagus


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?